Biblio

Found 7 results
Author [ Keyword(Desc)] Title Type Year
Filters: Author is Ozols, R. F.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
80 and over Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Area Under Curve Carboplatin/*administration & dosage Cisplatin/*administration & dosage Combined Modality Therapy Female Humans Middle Aged Neoplasm Staging Ovarian Neoplasms/*d
R. F. Ozols, Bundy, B. N., Greer, B. E., Fowler, J. M., Clarke-Pearson, D. L., Burger, R. A., Mannel, R., DeGeest, K., Hartenbach, E. M., Baergen, R., and Group, G. Oncology, Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study, J Clin Oncol, vol. 21, pp. 3194-200, 2003.
Adult Aged Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Carboplatin/administration & dosage Carcinoma/*drug therapy/pathology/surgery Cisplatin Female Humans Infusions
M. A. Bookman, Greer, B. E., and Ozols, R. F., Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5, Int J Gynecol Cancer, vol. 13, pp. 735-40, 2003.
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Carboplatin/administration & dosage Cisplatin/administration & dosage Cyclophosphamide/administration & dosage Female Humans Ovarian Neoplasms/*drug therapy Paclitaxel/administration & dosage
R. F. Ozols, Markman, M., and Thigpen, J. T., ICON3 and chemotherapy for ovarian cancer, Lancet, vol. 360, pp. 2086-7; author reply 2088, 2002.
Clinical Trials as Topic/*methods Combined Modality Therapy Female Humans Ovarian Neoplasms/*therapy
J. B. Vermorken, Parmar, M. K. B., Brady, M. F., Eisenhauer, E., Högberg, T., Ozols, R. F., Rochon, J., Rustin, G. J. S., Sagae, S., Verheijen, R. H. M., InterGroup, G. Cancer, ,, /NCRI, M. R. C., ,, -CTG, N. C. I. C., ,, -OVAR, A. G. O., and , Clinical trials in ovarian carcinoma: study methodology, Ann Oncol, vol. 16 Suppl 8, pp. viii20-viii29, 2005.
Intravenous Middle Aged Ovarian Neoplasms/*drug therapy/pathology/surgery Paclitaxel/administration & dosage Prognosis Second-Look Surgery Survival Analysis Treatment Outcome
M. A. Bookman, Greer, B. E., and Ozols, R. F., Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5, Int J Gynecol Cancer, vol. 13, pp. 735-40, 2003.